Veru Stock Set to Reverse Split on Monday, August 11th (NASDAQ:VERU)

Key Points

• Veru Inc. is set to conduct a 1-10 reverse stock split on Monday, August 11th, as announced on August 6th, with adjustments made after market close on August 8th.
• The stock currently trades at $0.37, reflecting a 18.7% decline, and the company has a market capitalization of $53.57 million with a PE ratio of -1.52.
• Institutional investors have recently increased their stakes in Veru, with Weaver Consulting Group growing its position by 27.4% in the first quarter.

Shares of Veru Inc. (NASDAQ:VERU - Free Report) are set to reverse split on Monday, August 11th. The 1-10 reverse split was announced on Wednesday, August 6th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, August 8th.

Veru Stock Down 18.7%

Veru stock opened at $0.37 on Thursday. The company has a market capitalization of $53.57 million, a PE ratio of -1.52 and a beta of -0.72. Veru has a 12-month low of $0.36 and a 12-month high of $1.42. The firm's fifty day moving average is $0.58 and its 200 day moving average is $0.57.

Veru (NASDAQ:VERU - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.01. Sell-side analysts expect that Veru will post -0.22 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Weaver Consulting Group grew its stake in Veru by 27.4% in the first quarter. Weaver Consulting Group now owns 88,838 shares of the company's stock valued at $44,000 after acquiring an additional 19,133 shares during the period. Cetera Investment Advisers grew its position in Veru by 26.1% in the 4th quarter. Cetera Investment Advisers now owns 95,210 shares of the company's stock valued at $62,000 after purchasing an additional 19,724 shares during the period. Wells Fargo & Company MN increased its stake in Veru by 37.1% during the 4th quarter. Wells Fargo & Company MN now owns 75,512 shares of the company's stock valued at $49,000 after purchasing an additional 20,430 shares in the last quarter. Integrated Wealth Concepts LLC increased its stake in Veru by 31.3% during the 4th quarter. Integrated Wealth Concepts LLC now owns 85,900 shares of the company's stock valued at $56,000 after purchasing an additional 20,500 shares in the last quarter. Finally, Barclays PLC raised its holdings in Veru by 11.8% during the fourth quarter. Barclays PLC now owns 206,515 shares of the company's stock worth $134,000 after buying an additional 21,738 shares during the last quarter. 47.16% of the stock is owned by institutional investors and hedge funds.

Veru Company Profile

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.